ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.8075A>G (p.Asp2692Gly)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV003187243 SCV003853801 uncertain significance Hereditary cancer-predisposing syndrome 2023-01-24 criteria provided, single submitter clinical testing The p.D2692G variant (also known as c.8075A>G), located in coding exon 17 of the BRCA2 gene, results from an A to G substitution at nucleotide position 8075. The aspartic acid at codon 2692 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.